… antagonist protocol. The aim of this study was to assess the … endometrial thickness on
the HCG day and IVF outcome in normal responders after GnRH antagonist administration. …

… difference in mean endometrial thickness on day of hCG administration between pregnant …
flexible multidose GnRH antagonist protocol. Many previous studies of GnRH agonists cycles, …

… antagonist administration, and will correlate the endometrial … optimal start criteria for antagonist
administration and this is … endometrial thickness at time of initiating GnRH antagonist in …

… dating and the endometrial thickness in the control and GnRH antagonist-treated cycles.
All … Even though our data suggest that the administration of GnRH antagonist to regularly …

… pA, Geneva, Switzerland, Specification: 5.5 μg or 75 IU) was administered on the second
or … After Gn was administered for 4–5 days, the dose was adjusted according to the patient’s …

… on the day of human chorionic gonadotrophin (hCG) administration (10.79 ±2.62 mm vs. …
GnRH agonist protocol compared with the short GnRH agonist protocol and GnRH antagonist …

… cetrorelix on the endometrium when administered at any phase … endometrial thickness
(double layer) of 2.5 mm on transvaginal scanning (TVS). The double-layer endometrial thickness …

… Endometrial thickness was measured via transvaginal … the GnRh antagonist elagolix
represents the most intriguing novelty for an actual clinical use in the management of endometriosis. …

… of the GnRH analogues used during COH on endometrial receptivity… than the midluteal long
GnRH agonist suppressive protocol (… endometrial thickness on the day of hCG administration …

… Endometrial thickness was also similar between the two … In conclusion, GnRH antagonist
administration during the … In conclusion, GnRH antagonist administration in the proliferative …